Integer Holdings Corporation (ITGR)
- Previous Close
123.27 - Open
114.00 - Bid 111.12 x 800
- Ask 111.08 x 800
- Day's Range
109.99 - 120.00 - 52 Week Range
69.40 - 123.99 - Volume
1,605,659 - Avg. Volume
349,817 - Market Cap (intraday)
3.724B - Beta (5Y Monthly) 1.12
- PE Ratio (TTM)
41.32 - EPS (TTM)
2.69 - Earnings Date Apr 25, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
124.86
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
www.integer.netRecent News: ITGR
Performance Overview: ITGR
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ITGR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ITGR
Valuation Measures
Market Cap
4.13B
Enterprise Value
5.16B
Trailing P/E
45.83
Forward P/E
23.15
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.61
Price/Book (mrq)
2.72
Enterprise Value/Revenue
3.23
Enterprise Value/EBITDA
19.79
Financial Highlights
Profitability and Income Statement
Profit Margin
5.68%
Return on Assets (ttm)
3.99%
Return on Equity (ttm)
6.17%
Revenue (ttm)
1.6B
Net Income Avi to Common (ttm)
90.65M
Diluted EPS (ttm)
2.69
Balance Sheet and Cash Flow
Total Cash (mrq)
23.67M
Total Debt/Equity (mrq)
69.34%
Levered Free Cash Flow (ttm)
47.7M
Research Analysis: ITGR
Company Insights: ITGR
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: ITGR
Analyst Report: Integer Holdings Corp
Based in Plano, Texas, Integer Holdings is a developer and manufacturer of medical devices and components. Its Medical business includes portable medical, cardio & vascular, and cardiac and neuromodulation products. Its Non-Medical division includes the Electrochem product line, which develops batteries for use in the energy, military, and environmental markets. ITGR shares are a component of the Russell 2000 Index. The company has approximately 7,500 employees.
RatingPrice TargetMarket Update: NVS, BYD, CVX, DE, ITGR, CBOE, FTV
Stocks are trading lower on Tuesday morning on some weaker-than-expected economic data as well as growing concerns that AI-related stocks are overbought at this juncture. Specifically, the Conference Board's Leading Economic Index slipped 0.4% in January and was lower than the expected 0.3% drop. The index was down 3.0% over the past six months -- a narrower decline than the preceding six-month period, which fell by 4.1%. Still, with six of the 10 index components being positive over the past six-month period, the index no longer is signaling a recession ahead. Turning to stocks, shares of Nvidia (NVDA) are down today, with the company reporting earnings tomorrow after market close. Despite expectations for positive earnings results, the selloff indicates many investors may be concerned that the shares are due for a pullback following an impressive run this year (which saw shares rise over 50% to an all-time high set last week). Shares of other tech companies which also saw strong gains related to AI prospects are trading lower on overvaluation concerns, including Arm Holdings (ARM), Advanced Micro Devices (AMD), and Super Micro Computer (SMCI).
Technical Assessment: Neutral in the Intermediate-Term
The stock market broadened on Tuesday, as some money rotated from mega-Tech and other highflyers into Basic Materials (XLB +1.8%), Real Estate (XLRE +1.5%), Healthcare (XLV +1.1%), and Industrials (XLI +0.9%). More importantly, two of those important S&P 500 sectors, XLI and XLV, have broken out of massive bases to all-time highs. The S&P 500 (SPX) rose 0.2%, the Nasdaq was flat, and the Nasdaq 100 (QQQ) fell 0.2%, all while the NYSE tacked on 0.8%, the S&P 400 was up 0.5%, and the Russell 2000 popped 0.9%.
Technical Assessment: Neutral in the Intermediate-Term
The major stock indices remain stuck in fairly narrow ranges, while the rest of the market has been pretty weak in 2024. That weakness actually started in mid-December, and the daily NYSE advance/decline line has been in a downtrend channel for a month. However, we have not seen nearly enough price weakness from the S&P 500 (SPX), Nasdaq, or Nasdaq 100 (QQQ) to call for at least some short-term caution, although it sure looks like it is coming.